BGI Genomics announced the launch of COLOTECT 1.0 in Slovakia, in collaboration with its partner, Zentya. Zentya is a Slovak-based company that is passionate about providing patients with the latest technology in genetic screening, aiming to help identify and facilitate timely treatments. COLOTECT 1. 0 is one of the first-ever fecal DNA tests for colorectal cancer that is available in Slovakia.

It is a non-invasive fecal DNA test for detecting colorectal cancer and precancerous lesions. It uses multiplexmethylation-specific PCR technology to trace abnormal colorectal cancer DNA-methylation biomarkers from fecal samples.